JP2002506448A5 - - Google Patents

Download PDF

Info

Publication number
JP2002506448A5
JP2002506448A5 JP1999505006A JP50500699A JP2002506448A5 JP 2002506448 A5 JP2002506448 A5 JP 2002506448A5 JP 1999505006 A JP1999505006 A JP 1999505006A JP 50500699 A JP50500699 A JP 50500699A JP 2002506448 A5 JP2002506448 A5 JP 2002506448A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1999505006A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002506448A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/013080 external-priority patent/WO1998058670A1/en
Publication of JP2002506448A publication Critical patent/JP2002506448A/ja
Publication of JP2002506448A5 publication Critical patent/JP2002506448A5/ja
Ceased legal-status Critical Current

Links

JP50500699A 1997-06-24 1998-06-24 抗髄膜炎菌ワクチン組成物を使用して成体を免疫する方法 Ceased JP2002506448A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5058197P 1997-06-24 1997-06-24
US60/050,581 1997-06-24
PCT/US1998/013080 WO1998058670A1 (en) 1997-06-24 1998-06-24 Methods of immunizing adults using anti-meningococcal vaccine compositions

Publications (2)

Publication Number Publication Date
JP2002506448A JP2002506448A (ja) 2002-02-26
JP2002506448A5 true JP2002506448A5 (https=) 2005-12-22

Family

ID=21966091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50500699A Ceased JP2002506448A (ja) 1997-06-24 1998-06-24 抗髄膜炎菌ワクチン組成物を使用して成体を免疫する方法

Country Status (4)

Country Link
US (1) US6413520B1 (https=)
EP (1) EP0994723A1 (https=)
JP (1) JP2002506448A (https=)
WO (1) WO1998058670A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2166097T5 (es) * 1996-08-27 2007-03-16 Novartis Vaccines And Diagnostics, Inc. Glicoconjugados de neisseria meningitidis de serogrupo b y procedimientos para usarlos.
US6248334B1 (en) * 1997-01-08 2001-06-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process
BR9910749A (pt) * 1998-05-29 2001-02-13 Chiron Corp Composições e vacinas imunogênicas combinadas para meningites b e c e método de induzir uma resposta imune por administração da mesma
ATE216875T1 (de) * 1999-01-27 2002-05-15 Idea Ag Nichtinvasive impfung durch die haut
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
OA12590A (en) * 2001-01-23 2006-06-08 Aventis Pasteur Multivalent meningococcal polysaccharide-protein conjugate vaccine.
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
AU2014218428B2 (en) * 2001-06-20 2016-08-25 Glaxosmithkline Biologicals Sa Capsular polysaccharide solubilisation and combination vaccines
NZ536859A (en) * 2002-05-14 2007-11-30 Chiron Srl Mucosal combination vaccines for bacterial meningitis
ES2461350T3 (es) 2003-01-30 2014-05-19 Novartis Ag Vacunas inyectables contra múltiples serogrupos de meningococos
MXPA05014015A (es) * 2003-06-23 2006-03-17 Baxter Int Vacunas contra grupo y nisseria meningitidis y combinaciones meningococales del mismo.
CN101443454A (zh) * 2005-12-22 2009-05-27 圣诺菲·帕斯图尔公司 多价脑膜炎球菌衍生化的多糖-蛋白质缀合物和疫苗
US10828361B2 (en) 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
PL2004225T3 (pl) 2006-03-22 2012-09-28 Novartis Ag Schematy immunizacji koniugatami meningokokowymi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727136A (en) 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
DE69019164T2 (de) 1989-12-14 1995-09-07 National Research Council Of Canada, Ottawa, Ontario Verbessertes meningokokkale polysaccharidkonjugatvakzin.
US5425946A (en) * 1992-08-31 1995-06-20 North American Vaccine, Inc. Vaccines against group C Neisseria meningitidis
PL175595B1 (pl) * 1992-08-31 1999-01-29 North American Vaccine Inc Antygenowy/immunogenny koniugat do wytwarzania szczepionki przeciwko infekcji N.meningitidis, sposób wytwarzania antygenowego/immunogennego koniugatu oraz szczepionka przeciwko infekcji N.meningitidis
ES2166097T5 (es) 1996-08-27 2007-03-16 Novartis Vaccines And Diagnostics, Inc. Glicoconjugados de neisseria meningitidis de serogrupo b y procedimientos para usarlos.

Similar Documents

Publication Publication Date Title
JP2000509635A5 (https=)
JP2000509637A5 (https=)
JP2000507042A5 (https=)
JP2000509912A5 (https=)
JP2000509942A5 (https=)
JP2000510751A5 (https=)
JP2000509587A5 (https=)
JP2000507369A5 (https=)
JP2000507433A5 (https=)
JP2000508866A5 (https=)
JP2000510793A5 (https=)
JP2000508022A5 (https=)
JP2000508841A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2000510247A5 (https=)
JP2000510969A5 (https=)
JP2000508836A5 (https=)
JP2000508102A5 (https=)
JP2000509818A5 (https=)
JP2000509520A5 (https=)
JP2000507434A5 (https=)
JP2000508880A5 (https=)